𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cyclooxygenase-2 expression in lung cancer cells evaluated by immunocytochemistry

✍ Scribed by Andrea Koch; Bertil Gustafsson; Helena Fohlin; Sverre Sörenson


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
172 KB
Volume
39
Category
Article
ISSN
8755-1039

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Fibronectin stimulates human lung carcin
✍ Shouwei Han; Neil Sidell; Susanne Roser-Page; Jesse Roman 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 453 KB

## Abstract Tobacco use is the most important risk factor for the development of lung carcinoma. One characteristic shared by tobacco‐related lung diseases is altered lung connective tissue content and composition. In particular, tobacco results in increased expression of fibronectin (FN), a matrix

Phosphoglycerate kinase 1-overexpressing
✍ Shye-Jye Tang; Ming-Yi Ho; Huan-Chieh Cho; Ying-Chun Lin; Guang-Huan Sun; Kwan-H 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 507 KB

## Abstract In addition to the known function in the glycolytic pathway, phosphoglycerate kinase 1 (PGK‐1) promotes reduction of plasmin disulfide bonds leading to angiostatin formation and inhibition of tumor angiogenesis. In this study, the effects of PGK‐1 on anti‐ tumor immunity against lung ca

Enhanced expression of cyclooxygenase (C
✍ Yuko Higashi; Takuro Kanekura; Tamotsu Kanzaki 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 129 KB 👁 2 views

Cyclooxygenase (COX)-2 is one of the rate-limiting enzymes in the conversion of arachidonic acid to prostaglandins and other eicosanoids. Recent studies have shown enhanced expression of COX-2 in cancer cells of several tissues. We investigated the expression of COX-2 and prostaglandin (PG) E 2 prod